U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 1010

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr22:51065685
GRCh38:
Chr22:50627257
ARSAK125T, K39TMetachromatic leukodystrophyPathogenic
(Jul 27, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr22:51064623-51064624
GRCh38:
Chr22:50626195-50626196
ARSAR227fs, R313fsMetachromatic leukodystrophyLikely pathogeniccriteria provided, single submitter
3.
GRCh37:
Chr22:51065326
GRCh38:
Chr22:50626898
ARSAA121D, A207DMetachromatic leukodystrophyLikely pathogeniccriteria provided, single submitter
4.
GRCh37:
Chr22:51066101
GRCh38:
Chr22:50627673
ARSAG36EMetachromatic leukodystrophyUncertain significance
(Feb 23, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr22:51064412
GRCh38:
Chr22:50625984
ARSAMetachromatic leukodystrophyUncertain significance
(Aug 11, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr22:51063703
GRCh38:
Chr22:50625275
ARSAQ381P, Q467PMetachromatic leukodystrophyUncertain significance
(Sep 2, 2020)
criteria provided, single submitter
7.
GRCh37:
Chr22:51064623
GRCh38:
Chr22:50626195
ARSAR227L, R313LMetachromatic leukodystrophyUncertain significancecriteria provided, single submitter
8.
GRCh37:
Chr22:51065605
GRCh38:
Chr22:50627177
ARSAS152T, S66TMetachromatic leukodystrophyUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr22:51066010
GRCh38:
Chr22:50627582
ARSAMetachromatic leukodystrophyLikely benign
(Sep 3, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr22:50167881-51066207
Metachromatic leukodystrophy, not providedPathogenic
(Oct 13, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr22:51063573-51064511
ARSAMetachromatic leukodystrophyPathogenic
(Aug 21, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr22:51064466
GRCh38:
Chr22:50626038
ARSAMetachromatic leukodystrophyLikely benign
(Jun 25, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr22:51063674
GRCh38:
Chr22:50625246
ARSAS391C, S477CMetachromatic leukodystrophyUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr22:51066019
GRCh38:
Chr22:50627591
ARSAMetachromatic leukodystrophyLikely benign
(Sep 4, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr22:51065327
GRCh38:
Chr22:50626899
ARSAA121T, A207TMetachromatic leukodystrophyUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr22:51064099
GRCh38:
Chr22:50625671
ARSAQ287P, Q373PMetachromatic leukodystrophy, Inborn genetic diseasesUncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr22:51063851
GRCh38:
Chr22:50625423
ARSAA332T, A418TMetachromatic leukodystrophyUncertain significance
(Jan 15, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr22:51066183
GRCh38:
Chr22:50627755
ARSAL9IMetachromatic leukodystrophyUncertain significance
(Apr 11, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr22:51065499
GRCh38:
Chr22:50627071
ARSAMetachromatic leukodystrophyLikely benign
(Sep 6, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr22:51065378
GRCh38:
Chr22:50626950
ARSAE104Q, E190QMetachromatic leukodystrophyUncertain significance
(Mar 18, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr22:51063668
GRCh38:
Chr22:50625240
ARSAV393M, V479MMetachromatic leukodystrophyUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr22:51064125
GRCh38:
Chr22:50625697
ARSAMetachromatic leukodystrophyLikely benign
(Mar 23, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr22:51065613
GRCh38:
Chr22:50627185
ARSAI149T, I63TMetachromatic leukodystrophyUncertain significance
(Jun 23, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr22:51065758
GRCh38:
Chr22:50627330
ARSAG101C, G15CMetachromatic leukodystrophyLikely pathogenic
(Oct 4, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr22:51065194
GRCh38:
Chr22:50626766
ARSAMetachromatic leukodystrophyLikely benign
(Oct 10, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr22:51065073
GRCh38:
Chr22:50626645
ARSAI267T, I181TMetachromatic leukodystrophyUncertain significance
(Sep 12, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr22:51064419
GRCh38:
Chr22:50625991
ARSAP265L, P351LMetachromatic leukodystrophyUncertain significance
(Jul 5, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr22:51066198
GRCh38:
Chr22:50627770
ARSAG4RMetachromatic leukodystrophyUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr22:51065053
GRCh38:
Chr22:50626625
ARSAE188K, E274KMetachromatic leukodystrophyUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr22:51065582
GRCh38:
Chr22:50627154
ARSAMetachromatic leukodystrophyLikely benign
(May 21, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr22:51063611
GRCh38:
Chr22:50625183
ARSAR412C, R498CMetachromatic leukodystrophyUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr22:51065084
GRCh38:
Chr22:50626656
ARSAMetachromatic leukodystrophyLikely benign
(Feb 19, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr22:51064583
GRCh38:
Chr22:50626155
ARSAMetachromatic leukodystrophyUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr22:51064619
GRCh38:
Chr22:50626191
ARSAMetachromatic leukodystrophyLikely benign
(Jun 8, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr22:51065381
GRCh38:
Chr22:50626953
ARSAV103M, V189MInborn genetic diseases, Metachromatic leukodystrophyUncertain significance
(May 18, 2023)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr22:51064725-51064726
GRCh38:
Chr22:50626297-50626298
ARSAMetachromatic leukodystrophyLikely benign
(Jul 25, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr22:51065448
GRCh38:
Chr22:50627020
ARSAMetachromatic leukodystrophyUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
38.
GRCh37:
Chr22:51065577
GRCh38:
Chr22:50627149
ARSAMetachromatic leukodystrophyLikely benign
(May 23, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr22:51065576-51065577
GRCh38:
Chr22:50627148-50627149
ARSAMetachromatic leukodystrophyLikely benign
(May 23, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr22:51065736
GRCh38:
Chr22:50627308
ARSAT108I, T22IMetachromatic leukodystrophyUncertain significance
(May 8, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr22:51065632
GRCh38:
Chr22:50627204
ARSAF57L, F143LMetachromatic leukodystrophyPathogenic
(Oct 21, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr22:51066092
GRCh38:
Chr22:50627664
ARSAG39DMetachromatic leukodystrophyUncertain significance
(May 25, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr22:51064564
GRCh38:
Chr22:50626136
ARSAMetachromatic leukodystrophyLikely benign
(Oct 17, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr22:51064572
GRCh38:
Chr22:50626144
ARSAMetachromatic leukodystrophyLikely benign
(Sep 25, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr22:51063880
GRCh38:
Chr22:50625452
ARSAS322T, S408TMetachromatic leukodystrophyLikely pathogenic
(Oct 17, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr22:51063895
GRCh38:
Chr22:50625467
ARSAMetachromatic leukodystrophyUncertain significance
(Aug 8, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr22:51065002
GRCh38:
Chr22:50626574
ARSAMetachromatic leukodystrophyLikely benign
(Sep 19, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr22:51064068
GRCh38:
Chr22:50625640
ARSAD297E, D383EMetachromatic leukodystrophyUncertain significance
(May 29, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr22:51063650
GRCh38:
Chr22:50625222
ARSAP399S, P485SMetachromatic leukodystrophyUncertain significance
(May 28, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr22:51064691
GRCh38:
Chr22:50626263
ARSAMetachromatic leukodystrophyLikely benign
(Jun 12, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr22:51063695
GRCh38:
Chr22:50625267
ARSAA384T, A470TMetachromatic leukodystrophyUncertain significance
(Feb 10, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr22:51063989
GRCh38:
Chr22:50625561
ARSAMetachromatic leukodystrophyLikely benign
(Oct 29, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr22:51065108
GRCh38:
Chr22:50626680
ARSAE169D, E255DMetachromatic leukodystrophyUncertain significance
(May 15, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr22:51064588
GRCh38:
Chr22:50626160
ARSAA239T, A325TMetachromatic leukodystrophyUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr22:51066170
GRCh38:
Chr22:50627742
ARSAL13QMetachromatic leukodystrophyUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr22:51065647
GRCh38:
Chr22:50627219
ARSAP52T, P138TMetachromatic leukodystrophyPathogenic
(Jan 28, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr22:51065623
GRCh38:
Chr22:50627195
ARSAF60L, F146LMetachromatic leukodystrophyLikely pathogenic
(Sep 26, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr22:51064654
GRCh38:
Chr22:50626226
ARSAG217R, G303RMetachromatic leukodystrophyPathogenic
(Aug 20, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr22:51063824
GRCh38:
Chr22:50625396
ARSAP341S, P427Snot specified, Metachromatic leukodystrophyConflicting interpretations of pathogenicity
(May 19, 2023)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr22:51065846
GRCh38:
Chr22:50627418
ARSAMetachromatic leukodystrophyLikely benign
(Oct 24, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr22:51063809
GRCh38:
Chr22:50625381
ARSAD432N, D346NMetachromatic leukodystrophyUncertain significance
(May 8, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr22:51063615
GRCh38:
Chr22:50625187
ARSAMetachromatic leukodystrophyLikely benign
(May 5, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr22:51065036
GRCh38:
Chr22:50626608
ARSAMetachromatic leukodystrophyLikely benign
(Nov 3, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr22:51065828
GRCh38:
Chr22:50627400
ARSAMetachromatic leukodystrophyLikely benign
(Jul 19, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr22:51063806
GRCh38:
Chr22:50625378
ARSAMetachromatic leukodystrophyLikely benign
(Apr 20, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr22:51065285-51065286
GRCh38:
Chr22:50626857-50626858
ARSAF135fs, F221fsMetachromatic leukodystrophyPathogenic
(Apr 18, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr22:51065376
GRCh38:
Chr22:50626948
ARSAMetachromatic leukodystrophyLikely benign
(Apr 17, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr22:51065665
GRCh38:
Chr22:50627237
ARSAP46S, P132SMetachromatic leukodystrophyUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr22:51065469
GRCh38:
Chr22:50627041
ARSAMetachromatic leukodystrophyLikely benign
(Apr 12, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr22:51065673
GRCh38:
Chr22:50627245
ARSAG129E, G43EMetachromatic leukodystrophyUncertain significance
(Apr 8, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr22:51065103
GRCh38:
Chr22:50626675
ARSAD257V, D171VMetachromatic leukodystrophyLikely pathogenic
(Apr 8, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr22:51066104
GRCh38:
Chr22:50627676
ARSAY35FMetachromatic leukodystrophyUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr22:51066032
GRCh38:
Chr22:50627604
ARSAL59PMetachromatic leukodystrophyUncertain significance
(Mar 11, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr22:51065795
GRCh38:
Chr22:50627367
ARSAMetachromatic leukodystrophyUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr22:51064610
GRCh38:
Chr22:50626182
ARSAMetachromatic leukodystrophyLikely benign
(Mar 8, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr22:51065180
GRCh38:
Chr22:50626752
ARSAMetachromatic leukodystrophyLikely benign
(Jul 13, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr22:51065464-51065484
GRCh38:
Chr22:50627036-50627056
ARSAMetachromatic leukodystrophyPathogenic
(Feb 22, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr22:51065462
GRCh38:
Chr22:50627034
ARSAT162A, T76AMetachromatic leukodystrophyUncertain significance
(Feb 22, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr22:51065372
GRCh38:
Chr22:50626944
ARSAQ106*, Q192*Metachromatic leukodystrophyPathogenic
(Aug 22, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr22:51065584
GRCh38:
Chr22:50627156
ARSAMetachromatic leukodystrophyLikely benign
(Jan 27, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr22:51065637
GRCh38:
Chr22:50627209
ARSAQ55fs, Q141fsMetachromatic leukodystrophyPathogenic
(Aug 9, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr22:51065671
GRCh38:
Chr22:50627243
ARSAV130M, V44MMetachromatic leukodystrophyUncertain significance
(Jan 3, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr22:51064511-51064512
GRCh38:
Chr22:50626083-50626084
ARSAMetachromatic leukodystrophyUncertain significance
(Jul 11, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr22:51065288
GRCh38:
Chr22:50626860
ARSAP134T, P220TMetachromatic leukodystrophyUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr22:51065388
GRCh38:
Chr22:50626960
ARSAN100K, N186KMetachromatic leukodystrophyUncertain significance
(Jan 12, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr22:51065050
GRCh38:
Chr22:50626622
ARSAE275K, E189KMetachromatic leukodystrophyUncertain significance
(Aug 1, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr22:51065266
GRCh38:
Chr22:50626838
ARSAS141F, S227FMetachromatic leukodystrophyLikely pathogenic
(Jan 11, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr22:51065783
GRCh38:
Chr22:50627355
ARSAMetachromatic leukodystrophyLikely benign
(May 8, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr22:51065415
GRCh38:
Chr22:50626987
ARSAMetachromatic leukodystrophyLikely benign
(Jan 1, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr22:51063611
GRCh38:
Chr22:50625183
ARSAR412fs, R498fsMetachromatic leukodystrophyUncertain significance
(Sep 6, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr22:51063733
GRCh38:
Chr22:50625305
ARSAA371V, A457VMetachromatic leukodystrophyUncertain significance
(Jun 4, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr22:51065300
GRCh38:
Chr22:50626872
ARSAR130C, R216CInborn genetic diseases, Metachromatic leukodystrophyUncertain significance
(Feb 11, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr22:51066097-51066098
GRCh38:
Chr22:50627669-50627670
ARSAMetachromatic leukodystrophyPathogenic
(Mar 22, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr22:51065751
GRCh38:
Chr22:50627323
ARSAP103R, P17RMetachromatic leukodystrophyUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr22:51065461
GRCh38:
Chr22:50627033
ARSAT162S, T76SMetachromatic leukodystrophyUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr22:51065795
GRCh38:
Chr22:50627367
ARSAMetachromatic leukodystrophyLikely benign
(Aug 9, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr22:51066039
GRCh38:
Chr22:50627611
ARSAG57RMetachromatic leukodystrophyUncertain significance
(Apr 28, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr22:51063772-51063773
GRCh38:
Chr22:50625344-50625345
ARSAL444fs, L358fsMetachromatic leukodystrophyPathogenic
(Dec 31, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr22:51065050
GRCh38:
Chr22:50626622
ARSAE275Q, E189QMetachromatic leukodystrophyUncertain significance
(Dec 17, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr22:51064441
GRCh38:
Chr22:50626013
ARSAA344P, A258PMetachromatic leukodystrophyUncertain significance
(Dec 25, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination